PURE MHC LEVERAGES THE HUMAN IMMUNE SYSTEM TO CREATE NOVEL THERAPEUTICS

Pure MHC, LLC is a platform technology company with expertise in disease-specific target identification andimmunotherapeutic drug discovery for cancer, infectious, and autoimmune diseases. Pure MHC identifies and leverages the same disease targets in drug discovery that the immune system uses to identify aberrant proteins in cancerous and infected cells.

1

HLA proteins act as an alarm system for cancerous and infected cells by presenting a foreign peptide to T cells.

2

A therapeutic response can be generated with the use of artificial T-cell receptors which are called T-cell receptor mimics (TCRm).